Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2018-04-03 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2018-04-03 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes information about the Annual Meeting of shareholders, voting instructions, and proxy materials availability. It is not the actual proxy statement or annual report itself but rather additional materials related to the proxy solicitation. The document is titled 'Definitive Additional Materials' and provides instructions on how to access the proxy materials and vote, which aligns with the definition of Proxy Solicitation & Information Statement (PSI).
2018-03-29 English
DEF 14A
Proxy Solicitation & Information Statement
2018-03-29 English
10-K
Annual Report FY 2017
2018-02-28 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes approval of a 2018 Incentive Plan for management bonuses, an amendment to the company's bylaws regarding director election voting standards, and the appointment of a new Chairman of the Board. These items relate to changes in management and governance structure. There are no financial statements or detailed financial results presented, so it is not an Annual Report, Interim Report, or Earnings Release. The focus on board appointments and bylaw amendments aligns with Board/Management Information filings. Therefore, the document is best classified as Board/Management Information (MANG). The document length and detail support a high confidence level.
2018-02-22 English
PRIMARY DOCUMENT
Director's Dealing
2018-02-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.